AHAbbas Hajizadeh

Abbas Hajizadeh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Abbas Hajizadeh has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Investigating the presence of virulence determinants and vancomycin-resistant genes in enterococci isolated from the Anzali Lagoon and recreational waters in Guilan Province, Iran

    by Hadis Kalantari, Khosro Issazadeh, Abbas Hajizade, Mohammad Faezi Ghasemi

    This study characterizes vancomycin-resistant Enterococci (VRE) in Iran's Anzali Lagoon recreational waters through analysis of 268 samples collected seasonally (2019). Culture and PCR methods identified Enterococcus in 57.5% (154/268) of samples, with 40.3% (62/154) showing vancomycin resistance. Resistance gene profiling revealed vanA and vanH predominance (56.5% each, 35/62), demonstrating complete co-occurrence, while vanB was rare (3.2%, 2/62) and vanC absent. Virulence factors displayed divergent prevalence: esp (62.9%, 39/62) exceeded clinical isolate rates, whereas hyl (3.2%, 2/62) was uncommon. Biofilm assays showed VRE isolates formed significantly denser biofilms than susceptible strains (2.3-fold higher OD570, p < 0.001), with esp-positive isolates exhibiting the strongest biofilm production. These findings demonstrate that recreational waters harbor VRE populations with: (1) elevated esp prevalence suggesting environmental selection pressures, and (2) enhanced biofilm capacity promoting persistence. The 100% vanA-vanH co-occurrence and 62.9% esp frequency surpass WHO risk thresholds for recreational waters, indicating need for revised monitoring protocols. This study provides the first evidence of aquatic-specific VRE genotypes in the region and their potential public health impacts through resistance gene dissemination and waterborne exposure risks.

  • Open Access

    Enterobactin: A key player in bacterial iron acquisition and virulence and its implications for vaccine development and antimicrobial strategies

    by Mohadese Amiri, Mehdi Golchin, Majid Jamshidian Mojaver, Hamidreza Farzin, Abbas Hajizade

    Enterobactin, a high-affinity siderophore produced by Escherichia coli and other enteric pathogens, plays a critical role in bacterial iron acquisition and virulence. By sequestering iron from host environments, enterobactin enables bacterial survival and proliferation, even under iron-limited conditions typical of host tissues. This review explores the biosynthesis and regulation of enterobactin, highlighting its contribution to bacterial pathogenesis and immune evasion. We discuss the potential of targeting enterobactin for the development of live-attenuated vaccines, emphasizing the attenuation of virulence through genetic knockout of enterobactin biosynthesis genes (e.g. entB). Additionally, we examine enterobactin as a promising target for novel antimicrobial strategies, including small-molecule inhibitors and siderophore-based "Trojan horse" antibiotics. Beyond medical applications, we also explore the biotechnological and environmental potential of enterobactin, such as its use in bioremediation and drug delivery systems. Finally, we identify key gaps in current research and propose future directions for harnessing enterobactin to combat bacterial infections and address global health challenges. This review underscores the multifaceted role of enterobactin in bacterial biology and its potential as a cornerstone for innovative therapeutic and biotechnological applications.


  • Antibacterial Activity of the Iranian Scorpion’s Crude Venom (Odontobuthus bidentatus) on Gram-positive and Gram-negative Bacteria

    by Hani Keshavarz Alikhani, Jamil Zargan, Ali Bidmeshkipour, Ashkan Haji Nour Mohammadi, Mohammad Hosseinpour, Ahmad Heydari, Abbas Hajizadeh

    Background: The venoms of some scorpions are rich in bioactive components that may be used in the development and discovery of new antibacterial drugs. The venoms have many components, such as neurotoxins, salts, proteins and peptides with therapeutic properties, and can rapidly eliminate a broad range of bacteria. This study evaluated the anti-bacterial activity of Odontobuthus bidentatus’ crude venom against typical Gram-positive and negative bacteria, such as Staphylococcus aureus, Bacillus subtilis, and Escherichia coli. Methods: The antibacterial effects of the crude venom were evaluated using Minimal Inhibitory Concentration (MIC) and MTT assays and its IC50 value was determined, using GraphPad software. Results: The crude venom significantly inhibited the growth of both Gram-positive and negative bacteria. Also the MTT results showed that the crude venom significantly reduced the viability of E. Coli, S. Aureus, and B. Subtilis bacteria compared with that for the controls. The IC50 values of the venom for E.coli, S.aureus, and B.subtilis were 30.19, 17.64, and 24.13 µM, respectively. Conclusion: The findings suggest that the venom of O. bidentatus scorpion has antibacterial properties. Also, our results offer preliminary clues toward the development of new antibacterial agents and new drugs with high therapeutic potentials for use in animals and humans.